Single Rapamycin Dose Reversed Autism Symptoms in Mice
SkimNews Take
Because symptoms reversed within hours but faded, the behaviors appear to be maintained by ongoing mTOR signaling rather than fixed developmental wiring — implying acute suppression rather than lasting repair.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- UCLA Health researchers found that even mild inflammation during pregnancy caused lasting autism-like changes in mouse offspring, including brain overactivity, sensory sensitivity, repetitive behaviors, and elevated seizure risk.
- A single dose of rapamycin improved nearly every symptom in the adult mice within about two hours, normalizing overactive neuron firing, reducing seizure vulnerability, restoring brain network communication, and easing repetitive and sensory behaviors.
- The two-hour response was too fast for rapamycin to have repaired the brain's physical structure, leading researchers to conclude the drug was rebalancing neuronal excitability rather than rebuilding synapses.
- Gene activity analysis showed rapamycin reversed abnormal expression patterns linked to autism, epilepsy, and ion channel function, with the strongest effects in excitatory neurons driven by reduced mTOR pathway signaling.
- Dr. Harley Kornblum, Dr. Janel Le Belle, and Dr. Neil Harris of UCLA authored the study, published in Nature Communications, with Le Belle as first author and Kornblum and Harris as senior authors.
- Researchers cautioned that rapamycin is not a viable human treatment: benefits were temporary, repeated dosing led to tolerance within weeks, and the drug carries known toxicity risks.
Why it matters: The finding shifts the therapeutic target from repairing brain structure to modulating brain function in adults, pointing autism research toward sensory circuit neuromodulation and balancing neuronal inhibition-excitation rather than rapamycin itself, which carries toxicity and tolerance problems that block clinical use.
